AI Navigate

Developing Foundation Models for Universal Segmentation from 3D Whole-Body Positron Emission Tomography

arXiv cs.CV / 3/13/2026

📰 NewsTools & Practical UsageModels & Research

Key Points

  • The paper announces SegAnyPET, a foundational model for universal segmentation in 3D whole-body PET imaging, built on what the authors claim is the largest PET dataset to date with 11,041 scans and 59,831 segmentation masks.
  • It introduces a 3D architecture with a prompt engineering strategy for mask generation, enabling generalizable segmentation across organs and lesions with zero-shot capabilities.
  • The model supports efficient human-in-the-loop workflows, facilitating easy human correction with minimal effort in clinical settings.
  • Extensive multi-center, multi-tracer, multi-disease evaluations demonstrate strong zero-shot performance across diverse segmentation tasks, highlighting potential clinical impact.

Abstract

Positron emission tomography (PET) is a key nuclear medicine imaging modality that visualizes radiotracer distributions to quantify in vivo physiological and metabolic processes, playing an irreplaceable role in disease management. Despite its clinical importance, the development of deep learning models for quantitative PET image analysis remains severely limited, driven by both the inherent segmentation challenge from PET's paucity of anatomical contrast and the high costs of data acquisition and annotation. To bridge this gap, we develop generalist foundational models for universal segmentation from 3D whole-body PET imaging. We first build the largest and most comprehensive PET dataset to date, comprising 11041 3D whole-body PET scans with 59831 segmentation masks for model development. Based on this dataset, we present SegAnyPET, an innovative foundational model with general-purpose applicability to diverse segmentation tasks. Built on a 3D architecture with a prompt engineering strategy for mask generation, SegAnyPET enables universal and scalable organ and lesion segmentation, supports efficient human correction with minimal effort, and enables a clinical human-in-the-loop workflow. Extensive evaluations on multi-center, multi-tracer, multi-disease datasets demonstrate that SegAnyPET achieves strong zero-shot performance across a wide range of segmentation tasks, highlighting its potential to advance the clinical applications of molecular imaging.